Development of a buccal doxepin platform for pain in oral mucositis derived from head and neck cancer treatment.

Artículo original

Año: 2017

Sanz R, Calpena AC, Mallandrich M, Gimeno Á, Halbaut L, Clares B.

Título: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

• Q1